Peptide Research
Retatrutide (GLP-3) Explained: Why This Triple Agonist Is Getting So Much Attention in Research
Retatrutide has rapidly become one of the most discussed investigational compounds in modern peptide and metabolic research. Much of that
Peptide Shipping Myth: Do Peptides Need Ice or Cold Shipping?
The Truth About Summer Shipping, Delays, and Lyophilized Peptide Stability Every year—especially during summer—we get the same worried message: “My
Structure’s Aleniglipron: Study Results, Oral GLP-1 Comparison, and Key Data
Structure Therapeutics has officially entered the serious oral GLP-1 conversation. Its once-daily oral study drug, aleniglipron, delivered one of the
Dihexa Research Compound: Mechanism, BDNF, HGF/c-Met & Laboratory Research
What Is Dihexa? Dihexa is a synthetic angiotensin IV-derived peptidomimetic compound that has become a topic of interest in preclinical
Amycretin vs GLP-1-Based Peptides: A Research-Based Comparison Guide (2026)
The Evolution of Metabolic Research Compounds The metabolic research space has shifted rapidly from single-pathway compounds to multi-mechanism designs aimed
RFK Jr., 14 Peptides, and FDA Category 2: Were Any Peptides Actually Approved?
In early March 2026, headlines began circulating across the biotechnology and peptide research community claiming that 14 peptides had been